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Ethylene Glycol Monoethyl Ether and
Ethylene Glycol Monoethyl Ether Acetate
Teratology Studies
by J. E. Doe*
An inhalation teratology study was conducted in rats at 10, 50 and 250 ppm ethylene glycol monoethyl
ether (EGEE) and in rabbits at 10, 50 and 175 ppm EGEE. This study was designed to supplement a study
conductedforNIOSHwhich showedteratogenic effects in rats at200 ppm EGEE and inrabbits at about 160
ppm EE. In this study, EGEE was found not to cause teratogenic effects at concentrations up to and
including 250 ppm in rats and 50 ppm in rabbits, while 175 ppm EGEE was considered to be a marginal
effect level forteratogenic effects in rabbits. Fetotoxicity was observed at 250 ppm EGEE and possibly at 50
ppm EGEE in rats.
An inhalation teratology study using ethylene glycol monoethyl ether acetate (EGEEA) has been
conducted in rabbits at25, 100 and 400 ppm. There was evidence ofteratogenicity (vertebral malformations)
at 400 ppm EGEEA and slight fetotoxicity at 100 ppm; 25 ppm was a no effect level.
Introduction
Ethylene glycol monoethyl ether, 2-ethoxyethanol
(EGEE) is a solvent for celluloses, acrylics, dyes, inks,
resins and varnishes. EGEE has aboilingpoint of135°C
at 760mm/Hgand a vapor pressure of4mm/Hg at200C.
Therefore, inhalation could be amajorroute ofexposure
for users of this material. In a previously reported
study (1), rats and rabbits were exposed to atmospheres
containing EGEE during gestation. Pregnant Wistar
rats were exposed to 767 or 202 ppm of EGEE for 7
hr/day on days 1 to 19 of gestation. At 767 ppm,
complete embryomortality and maternal toxicity were
seen, while at 202 ppm, fetal growth depression and an
increased incidence of terata compared with controls
were seen. Similar results were found when rabbits
were exposed to EGEE at either 617 or 160 ppm of
EGEE during gestation. Maternal toxicity and an
increase in the incidence ofembryomortality were seen
at both exposure levels, while at 160 ppm there was an
increase intheincidence ofterata. Therefore, ano-effect
level foreitherembryotoxicity orteratogenicity was not
established in either species. The purpose ofthe studies
reported here was to confirm the teratogenicity seen in
the previous study (1) and to determine a no-effect level
for embryotoxicity and teratogenicity for EGEE.
Ethylene glycol monoethyl ether acetate, 2-ethoxy-
ethanolacetate, (EGEEA) is asolvent fornitrocellulose,
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low viscosity cellulose and resins. EGEEA has a boiling
point of 156°C at 760 mm/Hg and a vapor pressure of
2 mm/Hg at 20°C.
Inhalation could therefore be a route of exposure for
users ofthis material. EGEEA has been reported (2) to
cause testicularatrophy and leukopeniain mice gavaged
for 5 days/week for 5 weeks. This was similar to the
effects seen with ethylene glycol monomethyl ether
(EGME) and EGEE in the same study. Both EGME
(3) and EGEE (1) have been shown to be teratogenic as
well as cause effects on the testis. Therefore, this study
was carried out to determine whether EGEEA would
also show teratogenicity as well as the effects on the
testis. EGEEA has been confirmed to be teratogenic in
rats (4), and for this reason only a rabbit inhalation
teratology study was carried out.
Both the studies on EGEE and the study on EGEEA
were sponsored by the Glycol Ethers Program Panel of
the Chemical Manufacturers Association, Washington,
DC, and reported to them by Tinston et al. (5-7).
Materials and Methods
Test Materials
Ethylene glycol monoethyl ether (EGEE) and eth-
ylene glycol monoethyl ether acetate (EGEEA) were
both supplied by Imperial Chemical Industries PLC,
Petrochemicals and Plastics Division, Wilton, Middles-
brough, UK. Both materials were more than 99% pure.J.E. DOE
Animals
Rats. Nulliparous specificpathogen-free femalerats
ofthe Alpk/AP (Wistar-derived) strain were used with a
weight range of 200 to 280 g. The animals were
approximately 11 to 13 weeks old. The rats were paired
overnight and the following morning the detection of
spermatozoa in vaginal smears was used as evidence of
mating. The day on which spermatozoa were detected
was termed day 0 of pregnancy.
Rabbits. Virgin female Dutch rabbits (5-7 months
old, 1.7-2.8 kg in weight) were supplied by Ranch
Rabbits, Crawley Down, Sussex, UK, and housed
individually in cages. They were acclimatized to the
exposure chambers, where they were individually
housed in wire mesh cages for no more than 6 hr/day for
at least 6 days prior to mating, during which time the
clinical condition of each rabbit was monitored. Twelve
bucks ofthe same strain and ofproven fertility supplied
by the same breeder were housed within the same
experimental unit. Each doe was placed with the buck
and coitus observed, a vaginal smear was taken from
the first doe each buck mated. The smear was examined
forthe presence ofmotile sperm. Within 5 hr ofmating,
each doe received an intravenous injection of 25 IU of
chorionic gonadotrophin (Pregnyl, Organon Labora-
tories Limited, Morden, Surrey, UK) to promote
ovulation. Dayofmatingwastermed day0 ofpregnancy.
Following mating the does were placed in exposure
chambers for 6 hr/day, but were not exposed to test
material until day 6 of gestation.
Exposure Chambers
The exposure chambers (8) had an internal volume of
approximately 3.4 mi3. They were constructed of stain-
less steel and access was gained to each chamber
through a door fitted with a safety glass window. Air
entered at the front ofeach chamber and was extracted
at the back. Within each chamber were 6 cage levels and
excreta collection trays which rotated concurrently
(0.5 times/min) with the direction of flow of the input
air. In each chamber, each of the levels supported four
cages and an air flow rate in each in each chamber of600
L/min was used. The chamber air supply was condi-
tioned to 22°C and 50% relative humidity, and the
temperature and relative humidity in each chamber
were recorded daily. The distribution of both EGEE
and EGEEA at equilibrium within the chambers was
found to be within + 5% of the nominal concentration.
Atmosphere Generation and Analysis
Atmospheres of both EGEE and EGEEA were
generated by metering appropriate amounts into a
condenser at 34 to 40°C and passing the vaporized test
compound into the input air of each chamber. The
concentrations of test substance in each chamber were
analyzed 9 to 14 times per exposure period through 4
mminternal diameter coppertubingleadingto a central
analyzer. The atmospheric concentrations were moni-
tored by using Wilks-Miran infrared analyzers with the
following conditions: EGEE, wavelength 8.9 ,um, slit
width 1 mm; EGEEA, wavelength 9.2 jim, slit width
1 mm. The pathlengths were adjusted according to the
concentration within a chamber.
Maternal Observations
Rats. The body weight ofeach rat was recorded on
day 0, 5, 6 to 15, 16 and 21. Food consumption was also
assessed over the same time period. Each animal was
observed daily for changes in clinical condition and
during the exposure period for any abnormalities.
Rabbits. The body weight of each rabbit was
recorded on day 0, daily on days 5 to 19 and on days 24
and 28. Food consumption was also measured over this
time period. The clinical condition of all animals was
recorded daily and they were observed during each
exposure for any abnormalities.
Terminal Investigations
Rats. On day 21 of pregnancy the rats were killed
by an overdose of Halothane BP and subjected to a
postmortem examination. Blood samples were taken by
cardiac puncture and placed in EDTA pots for hemato-
logical assessment. Thymus and spleen were weighed.
The uterus ofeach rat was dissected out and the gravid
uterus weighed. The number of corpora lutea in each
ovary was counted. The uterus was then opened by an
incision on the abendometrial wall and the number of
implantations of early and late uterine deaths were
counted. Intrauterine deaths were identified as being
late when fetal tissues were distinguishable. Each live
fetus was removed from the uterus by severing the
umbilical cord. It was then weighed and examined
externallyforgrossabnormalities, includingcleftpalate.
Approximately half of the fetuses in each litter were
fixed in 70% methanol. These fetuses were subse-
quently eviscerated and stained with Alizarin Red S for
skeletal examination. The remaining fetuses in each
litter were fixed in Bouin's fluid to be processed for
visceral examination.
Rabbits. Rabbits were killed on day 29 of preg-
nancy with an intravenous injection of pentobarbitone
sodium BP and subjected to apostmortem examination.
Blood samples were taken by cardiac puncture for
subsequent hematological analysis and femoral bone
marrow smears were prepared. The spleens were
weighed. The uterus was dissected out, the gravid
uterus was weighed, and the number ofcorpora lutea in
each ovary was counted. The uterus was opened by an
incision on the abendometrial wall, and the number of
implantations, early intrauterine deaths and late intra-
uterine deaths were counted. Intrauterine deaths were
identified as being late when fetal tissues were
distinguishable. Each live fetus was removed from the
uterus by severing the umbilical cord, and each fetus
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was then weighed and examined externally for gross
defects, including cleft palate.
Assessment of Fetuses
Rats. Visceral assessment of the methanol-fixed
fetuses consisted of examination of the abdominal and
thoracic contents. At this time, the sex of each fetus
was determined externally and confirmed by internal
examination. Most fetuses fixed in Bouin's fluid were
stored until decalcification was complete. They were
then transferred to 70% methanol, and the head and
thorax ofeach fetus was sectioned at approximately 1.5
to 2 mm intervals and the sections examined under a
stereo microscope (9). The abdominal organs were
examined in situ. Skeletons of all fetuses fixed in
methanol and stained with Alizarin Red S were exam-
ined under a stereo microscope to assess morphological
development and the degree of ossification. The indi-
vidual bones of the manus and pes were assessed and
the results converted into a four-point scale. Defects
were classified according to the scheme: major (rare or
possibly lethal or both) orminor deviations from normal
(deviations from normal that are common at external,
visceral or skeletal examination) defects. Variations in
the degree of ossification in the fetuses were also
recorded and classified as minor defects or variants,
depending upon frequency of occurrence in historical
control. Extrathoracic ribs were classified as variants.
Rabbits. During visceral examination, the skin was
removed from each fetus and the eyes examined for
opacities, the major organs ofthe abdomen and thorax
were examined in situ for defects, and the sex of the
fetus was determined. The position of major blood
vessels in the thorax and their emergence from the
heart were noted. A section across the heart was made
to check for any ventricular septal defects. All fetuses
were eviscerated and placed in 70% methanol. After
approximately 24 hr an incision was made along the
fronto-parietal suture line of each fetus in order to
examine the brain. All fetuses were then examined with
Alizarin Red S (10) and examined to assess morpholog-
ical development and the degree of ossification. The
individual bones of the manus and pes were assessed
and the result converted to a five-point scale.
Study Designs
The exposure concentrations and number ofrats used
in the rat EGEE study are shown in Table 1. The rats
were exposed totheappropriate concentration ofEGEE
for 6 hr/day on days 6 to 15 inclusive of gestation.
Exposure concentrations and number ofrabbits used
in the rabbit EGEE study are shown in Table 2. The
rabbits were exposed on days 6 to 18 inclusive of
gestation to the appropriate concentration ofEGEE for
6 hr/day.
Exposure concentrations and number ofrabbits used
in the rabbit EGEEA study are shown in Table 3. The
rabbits were exposed to the appropriate concentration




Atmosphere Concentrations. The overall atmo-
sphere concentrations were: 9.9 + 0.9 ppm; 50.8 ±
2.3 ppm; 249.2 + 10.4 ppm.
Maternal Observations. There were no treatment-
related effects upon either body weight or food
consumption. There were also no clinical changes in
clinical condition of the rats caused by exposure to
EGEE. Postmortem examination showed that the
spleen and thymus weights were not affected by expo-
sure to EGEE, and there were no other treatment-
related abnormalities. In the rats exposed to 250 ppm
EGEE there were reductions in hemoglobin, hemato-
crit and mean cell volume in the red blood cells, but
there were no effects at either 50 or 10 ppm ofEGEE.
Litter Data. There was a higher level of pre-
implantation loss in all exposed groups compared with
controls, although this was statistically significant only
inthe 10and 50ppmgroups (Table4). Post-implantation
losses were also slightly higher in the exposed groups
compared with controls, but these differences were not
Table 1. Rat EGEE study.
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Table 2. Rabbit EGEE study.
Group Exposure concentration Number of





Table 3. Rabbit EGEEA study.
Group Exposure concentration Number of






Table 4. Rat EGEE study.
Exposure concentration of EGEE
Control 10 ppm 50 ppm 250 ppm
No. pregnant 23/24 24/24 23/24 21/24
Pre-implantation loss, % 2.4 9.7 14.3* 6.2
Post-implantation loss, % 5.5 7.6 8.9 12.6
Mean no. of live fetuses 12.2 10.6* 10.8* 11.1
Mean live fetus weight, g 5.1 5.2 5.1 4.7
*Statistically significantly different from the controls, p < 0.05.
Table 5. Rat EGEE study: comparison of fetal visceral, external and skeletal defects.
Exposure concentration of EGEE
Control 10 ppm 50 ppm 250 ppm
External and visceral defects
No. (%) showing any minor defects 33 (11.7) 41 (16.1) 29 (11.6) 43 (18.4)*
No. (%) showing any major defects 0 0 0 1 (0.4)
Skeletal defects:
No. (%) showing any minor defects 68 (46.3) 52 (39.7) 66 (51.2) 119 (97.5)*
No. (%) showing any major defects 0 0 0 0
*Statistically significantly different from the controls p < 0.05.
Table 6. Rat EGEE study: incidence of specific visceral and external defects.
Exposure concentration of EGEE
Control 10 ppm 50 ppm 250 ppm
Minor defects
No. (%) renal pelvic dilation 19 (6.8) 25 (9.8) 22 (9.8) 30 (12.8)*
No. (%) hydroureter 13 (4.6) 26 (2.4) 4 (1.6) 10 (4.3)
No. (%) bladder distended 0 1 (0.4) 0 0
No. (%) dermal hemorrhage 2 (0.7) 2 (0.8) 0 0
No. (%) limb malrotation 0 9 (3.5)* 2 (0.8) 3 (1.3)
No. (%) lateral ventricles of brain dilated 0 0 1 (0.8) 0
Major defects
Right uterer/kidney fused to left kidney, right kidney vestigial 0 0 0 1 (0.4)
*Statistically significantly different from the controls, p < 0.05.
statistically significant and were within historical con-
trol values of 2 to 17% in this strain of rat. The
proportion of dams with any late intrauterine death
and the mean percentage late intrauterine deaths
was statistically significantly increased in the 250 ppm
group. The mean number of live fetuses was reduced
in the exposed groups compared with the controls, and
this was statistically significant in the 10 and 50 ppm
groups but not at 250 ppm. The lower litter sizes ofthe
exposed groups were reflected in reduced mean gravid
uterus weights and in reduced total litter weights.
Total litter weight was statistically significantly re-
duced in the 10 and 250 ppm groups, the reduction
being most marked at 250 ppm. While there was no
effect on mean fetal weight in the 10 and 50 ppm group,
this parameter was statistically significantly reduced
in the 250 ppm group.
Fetal, Visceral, External and Skeletal Defects.
The incidence of minor external and visceral defects
was slightly elevated in the 10 and 250 ppm groups
(Tables 5 and 6). The proportion offetuses affected was
statistically significantly higher in the 250 ppm group
than in the controls, but when considered on a litter
basis the increase was not statistically significant. The
increases were due to a higher incidence of limb
malrotation in the 10 ppm group and pelvic dilatation of
the kidney in the 250 ppm group. No cardiovascular
abnormalities were seen. There was an increased inci-
dence ofminor skeletal defects in the 250 ppm group, a
proportion offetuseshavingthese defects being statisti-
cally significantly increased. Examination ofthe specific
skeletal findings showed this to be the consequence of
increased partial/nonossification of parts of the skull,
the thoracic centra, the lumbar centra, the lumbar
vertebrae and sternebrae, increased sternebrae abnor-
malities and increased incidence of 27 presacral verte-
brae. There was little evidence of any increased inci-
dence ofthese effects in the 10 and 50 ppm groups, the
only statistically significant increases being the propor-
tion of fetuses with partially ossified lumbar vertebral
process in the 10 ppm group and partially ossified
second sternebrae and unossified cervical centra in the
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Table 7. Rabbit EGEE study: litter data.
Exposure concentration of EGEE
Control 10 ppm 50 ppm 175 ppm
No. pregnant and included in analyses 21/24 21/24 16/24 22/24
Pre-implantation loss, % 19.5 17.6 22.1 25.7
Post-implantation loss, % 5.7 8.4 8.8 5.7
Mean no. of live fetuses 6.5 6.6 6.0 6.1
Mean live fetus weight, g 34.1 34.2 35.7 36.1
Table 8. Rabbit EGEE study: comparison of fetal visceral, external and skeletal defects.
Exposure concentration of EGEE
Control 10 ppm 50 ppm 175 ppm
External and visceral defects
No. (%) showing any minor defects 6 (4.4) 8 (5.8) 4 (4.2) 2 (1.5)
No. (%) showing any major defect 1 (0.7) 1 (0.7) 0 2 (1.5)
Skeletal defects
No. (%) showing any minor defects 44 (32.4) 72 (52.2) 35 (36.5) 87 (64.5)*
No. (%) skeletal variants 70 (51.5) 84 (60.0) 62 (64.6) 106 (79.1)
*Statistically significantly different from the controls, p < 0.05.
Table 9. Rabbit EGEE study: incidence of major visceral effects.
Exposure concentration of EGEE
Control 10 ppm 50 ppm 175 ppm
Right subclavian artery, absent, aorta
and heart reduced in size (%) 0 0 0 1 (0.7)
Extreme pelvic dilatation of both kidneys 1 (0.7) 0 0 0
Umbilical hernia 0 0 0 1 (0.7)
50 ppm group. The development of manus and pes
were affected in the 250 ppm group, the mean scores
per fetus being significantly increased. There was no
effect on manus and pes development in the 10 and
50 ppm groups.
Rabbit EGEE Study
Atmosphere Analysis. The daily mean analyzed
concentration of EGEE were all within 10% of the
target concentration except for 2 days and the overall
concentrations were 10.1 + 0.03 ppm, 51 ± 4 ppm and
175 ± 3 ppm.
Maternal Observations. There were no effects due
to compound on body weight gain or food consumption
and no clinical abnormalities which could be attributed
to exposure to EGEE.
Litter Data. There was no evidence for any treat-
ment-related effects on the litter data (Table 7).
Fetal, External, Visceral and Skeletal Defects.
There were two major defects in the 175 ppm group: one
fetus had a cardiovascular defect (heart and aorta
reduced in size and the right subclavian artery was
missing), and another fetus had a ventral wall defect
(umbilical hernia) (Tables 8 and 9). There was one fetus
in the 10 ppm group with a major defect (right gonad
appeared male, and left gonad appeared female; this
defect was not found inthe other twogroups). One fetus
in the control group had a major defect (extreme pelvic
dilatation of the kidney). The incidence of skeletal
defects was statistically significantly greater in the 175
ppm than in the control group, largely as a result of
retarded ossification of the skeleton and an increased
incidence of 27 presacral vertebrae. The incidence of
minor skeletal defects was also increased in the 10 ppm
group in comparison with the control group but is not
considered to be treatment-related, as it was not
statistically significant and there was only a very slight
increase observed in the 50 ppm group. The incidence of
skeletal variants in the 175 ppm group was statistically
significantly greater than in the control group and this
was entirely due to an increased number offetuses with
extra ribs, both short and of normal length. The
incidence of skeletal variants was slightly increased in
the 10 and 50 ppm groups compared with controls, due
to an increase inthe incidence ofextraribs and partially
ossified 5th vertebrae. Since the incidence ofextra ribs
was not statistically significantly increased at either 10
or 50 ppm and the slightly increased incidence of
partially ossified 5th sternebrae was not dose-related,
these two specific defects were considered not to be
related to exposure to EGEE at 10 ppm. There was no
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effect due to exposure on the mean manus and pes
development scores.
EGEEA Rabbit Study
Atmosphere Analysis. The overall mean atmo-
sphere concentrations were 24.9 ± 0.7 ppm, 99
2 ppm, 412 ± 7 ppm.
Maternal Observations. There was a dose-related
adverse effect on body weight in all three groups, which
was only statistically significant in the rabbits exposed
to 400 ppm during the first few days of exposure.
There was a dose-related decrease in food consump-
tion, but this was also only statistically significant in
the 400 ppm group. There were no clinical abnormalities
which could be related to exposure to EGEEA in any of
the three groups. There was no effect on spleen weight
at postmortem, nor were there any other maternal
macroscopic observations which could be related to
EGEEA exposure. There was a statistically significant
reduction in hemoglobin concentration and a slight
reduction in the associated red blood cell parameters in
the rabbits exposed to 400 ppm.
Litter Data. There was an increased incidence of
intrauterine deaths in the 400 ppm group which was
associated with a higher percentage post-implantation
loss and the lower number of live fetuses per litter
(Table 10). When the data from three animals with total
resorptions were omitted from the 400 ppm group,
there were no statistically significant differences in
percentage post-implantation loss. Mean live fetal
weight was statistically significantly reduced in the 100
and 400 ppm groups. There were no statistically
significant differences from control values in the 25 ppm
group.
Fetal, External, Visceral and Skeletal Defects.
The incidence of fetuses with major defects (Tables 11
and 12) was: control group 1; 25 ppm group, 1; 100 ppm
group, 2; and 400 ppm group, 8.
In the 400 ppm group the fetuses with major defects
were from four different litters: two ofthe eight fetuses
had major external or visceral defects (brain ventricles
moderately dilated and both forelimbs malrotated) and
five had major skeletal defects associated with the
vertebral column with misaligned vertical arches and
additional hemivertebrae. One fetus had a major vis-
ceral defect (agenesis of the right kidney) and a major
skeletal defect of a similar nature to the others. There
were no major skeletal defects in the 25 or 100 ppm
EGEEA groups, but one fetus from the 25 ppm group
Table 10. Rabbit EGEEA study: litter data.
Exposure concentration of EGEE
Control 25 ppm 100 ppm 400 ppm
No. pregnant 16/24 15/24 17/24 19/21
Pre-implantation loss, % 14.0 19.1 8.2 12.3
Post-implantation loss, % 9.4 18.1 6.7 24.4*
Mean no. of live fetuses 6.6 5.1 7.4 4.9*
Mean total litter weight, g 230 194 223 179*
Mean live fetal weight, g 34.7 35.2 30.1* 30.8*
*Statistically significantly different from the controls, p < 0.05.
Table 11. Rabbit EGEEA study: comparison of fetal visceral, external and skeletal defects.
Exposure concentration of EGEE
Control 25 ppm 100 ppm 400 ppm
External and visceral
No. (%) showing minor defects 22 (20.8) 18 (23.4) 30 (27.0) 51 (54.8)*
No. (%) showing major defects 0 (0) 1 (1.3) 2 (1.8) 3 (3.2)
Skeletal
No. (%) variants 50 (47.2) 40 (51.9) 72 (64.9)* 92 (98.9)
No. (%) showing any defects 23 (21.7) 14 (18.2) 37 (33.3)* 91 (97.8)*
No. (%) showing major defects 1 (0.9) 0 0 6 (6.5)*
*Statistically significantly different from the controls, p < 0.05.
Table 12. Rabbit EGEEA study: incidence of major defects.
Exposure concentration of EGEEA
Control 25 ppm 100 ppm 400 ppm
No. (%) with moderate dilatation of brain ventricles 0 0 0 1 (1.1)
No. (%) with absent kidney 0 1 (1.3) 0 1 (1.1)
No. (%) with misplaced ovary 0 0 1 (0.9) 0
No. (%) with forelimb malrotated 0 0 1 (0.9) 1 (1.1)
No. (%) with multiple defects of vertebrae 1 (0.9) 0 0 6 (6.6)
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had agenesis ofthe left kidney and one fetus in the 100
ppm group had an ovary attached to the intestine.
Another fetus in the 100 ppm group had its right
forelimb malrotated. In the control group, one fetus had
a major vertebral defect. There were no cardiac abnor-
malities in this study.
In the 400 ppm group there was a statistically
significant increase in the proportion of fetuses with
minor external/visceral defects in comparison with the
control group. Within the 400 ppm group, there was a
statistically significant increase in the proportion of
fetuseswithpelvicdilation, opaque/emptygallbladders,
pale and reduced spleens. In the 100 ppm group the
proportion offetuses with pale spleen was also statisti-
cally significantly increased in comparison with the
control group. There were no statistically significant
increases in the proportion of fetuses with any specific
external or visceral defect in the 25 ppm group. The
proportion of fetuses with any external or visceral
defects was statistically significant only in the 400 ppm
group. In addition there was a statistically significant
increase in the proportion offetuses with minor skeletal
defects in the 400 ppm group which was indicative of
retarded ossification. In the 100 ppm group, the propor-
tion offetuses with minor skeletal defects were slightly
increased but not significantly. Two specific defects:
partial ossification ofthe first cervical centrum and the
second sternebrae were statistically significantly higher
in the 100 ppm group. The incidence of one minor
defect, an extra center of ossification above the first
sternebrae, was statistically significantly higher in the
25 ppm group. Statistically significant differences indi-
cating retarded ossification of the manus and pes were
observed in the 100 ppm group and for the pes alone in
the 400 ppm group. The proportion of fetuses with
skeletal variants was statistically significantly higher
than the 400 ppm groups. The incidence of 13 bilateral
ribs was significantly increased in both groups. There
were no statistically significant increases in variants in
the 25 ppm group.
Discussion
The only evidence for maternal toxicity in the EGEE
rat study was in the 250 ppm group, where statistically
significant reductions in hemoglobin, hematocrit and
the red cell volume were observed. These changes were
slight, butareconsistentwiththehematological changes
seen in other studies with glycol ethers including
EGEE (2,11). At 250 ppm there was a marked increase
in the incidence of late uterine deaths and in the
proportion of dams affected, indicating an increased
post-implantation loss. There was also a decrease in
mean fetal weights in the 250 ppm groups; thus 250 of
EGEE caused an increased post-implantation loss and
retarded fetal growth, although no effects were seen at
50 or 10 ppm. The slightly increased incidences offetal
visceral and external defects in the 10 and 250 ppm
groups were due to limb malrotation in the 10 ppm
group and renal pelvic dilatation in the 250 ppm group.
There were no statistically significant increases in the
incidence of limb malrotation in the 50 and 250 ppm
groups, and therefore this defect is considered to have
no toxicological significance. The association of renal
pelvic dilation with exposure to 250 ppm cannot be
precluded, but the defect is a minor one and not
indicative of teratogenicity. No major skeletal defects
were identified in this study, but overall there was a
fetotoxic effect at 250 ppm, indicated by reduced
ossification, which could be related to the retarded fetal
growth observed at this level. The increased incidence
of skeletal variants in the 250 ppm group was also con-
sistent with a fetotoxic effect. A small number ofthese
changes occurred at 50 ppm, i.e., unossified cervical
centra and extra ribs, and these could represent aslight
fetotoxic effect. Slight fetoxicity is also indicated by
partial ossification ofthe second sternebrae at 50 ppm.
The minor changes in ossification ofthe cervical centra
seen at 10 ppm are normally reversible once treatment
ceases and are therefore considered to be of minimal
toxicological importance. In addition, the increased
incidence at 10 ppm was within the historical range for
this strain of rat.
The results ofthe study reported here are similar to
those given previously (1), where pregnant female rats
were exposed to 200 ppm ofEGEE for 7 hr/day on days
1 to 19 of gestation. Fetal body weights were reduced,
and this effect was accompanied by skeletal defects
including retarded ossification. There was also a low
incidence of cardiovascular abnormalities: 6 out of 324
fetuses were affected, whereas no cardiac abhormalities
were seen in the 234 fetuses exposed to 250 ppm in this
study. The exposure levels used in the two studies were
very similar, especially when the slightly loger expo-
sure period (7 hr/day compared to 6 hr/day in the
previous study) are taken into account. It is unlikely
that different lengths of treatment (days 1-19 ofgesta-
tionversusdays6-15ofgestation)would haveinfluenced
the induction of cardiac abnormalities, as the sensitive
period of organogenesis is included in both periods. It
should be borne in mind that the incidence of cardiac
abnormalities in the previous study 6/324, 1.5% is low
and 200 to 250 ppmmaybe close to the threshold forthis
effect in rats. The data from the present study indicate
that EGEE is not teratogenic to rats exposed during
organogenesis at concentrations up to and including 250
ppm. It is, however, fetotoxic and shows mild maternal
toxicity (hematological changes) at 250 ppm and slight
fetotoxicity at 50 ppm.
In the rabbits exposed to EGEE there was no
evidence of maternal toxicity in either body weight,
food consumption or clinical condition. Although blood
cell counts were not carried out, there was no indication
of an effect on the bone marrows in the 175 ppm group.
There was also no evidence of embryotoxicity or
fetotoxicity from the litter data, since fetal weights,
numbers of fetuses and the incidence of intrauterine
deaths in the groups exposed to EGEE were similar to
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the controls. There were also no statistically significant
increases in the incidence of fetal, external or visceral
defects in any ofthe EGEE exposure levels inthe rabbit
study, but there was one fetus in the 175 ppm EGEE
group with a cardiovascular defect and one other fetus
in the same group with an abdominal wall defect.
At 175 ppm EGEE in the rabbit, both the incidence
and type ofminor skeletal defects and the occurrence of
extra rudimentary ribs are considered to be indicative
of fetotoxicity. The occurrence of extra normal length
ribs is regarded as indicating possible teratogenic
potential, which would be expressed at higher levels of
the relevant test compound (13). There was noincidence
of fetotoxicity in the 10 and 50 ppm groups, the slight
increase in the incidence ofunossified 5th sternebrae at
10 ppm is considered to be coincidental, since similar
increases were not apparent at 50 or 175 ppm. Other
changes were also not dose-related.
The results reported here are similar again to those
reported previously (1) when New Zealand White
rabbits were exposed to 160 ppm ofEGEE for 7 hr/day
on days 1 to 19 of gestation. In both the present study
and the other study, the incidence of skeletal variants
was increased, and there were no effects on fetal
weights. The main difference was that in the previous
study(1)therewas anincreaseinintrauterine mortality,
a slight increase in the incidence of a major cardiovas-
cular defect (5 out of 167 fetuses, 3% with fusion of
aorta and pulmonary artery) and a slightincrease in the
incidence ofventral wall defects. There was no evidence
for increased intrauterine mortality at 175 ppm in the
study reported here; the incidence of fetal major
cardiovascular defect (right subelavian artery absent,
heart and aorta reduced in size) was 1 out of134 fetuses
(0.7%), and the incidence of ventral wall defect was 1
out of 134 fetuses (0.7%).
While an incidence of major defects of 2 out of 134
fetuses examined would not normally be considered to
be evidence of a teratogenic effect, consideration ofthe
other studies where EGEE has been shown to cause
cardiac defects (1) suggests that 175 ppm could be
considered to be a marginal effect level for teratoge-
nicity in this study. However, 50 ppm EGEE was a clear
no-effect level forboth teratogenicity and fetotoxicity in
this study.
Taken overall, the results ofthe two studies reported
here for the effect ofEGEE in rats and rabbits indicate
that levels of 175 to 250 ppm may be around the
threshold level for teratogenicity; 175 to 250 ppm has
been shown to be fetotoxic in both rats and rabbits, and
50 ppm is mildly fetotoxic in rats, although there were
no effects in rabbits. These studies overall indicate a
marginal fetotoxic effect level of 50 ppm and a clear
no-effect level of 10 ppm in both species.
Exposure to 400 ppm of EGEEA caused some mild
toxicity in the rabbit, since there was an adverse effect
on weight gain during the exposure period and there
wasamarginalreductioninbloodhemoglobinconcentra-
tion in the 400 ppm groups. There was no evidence of
maternal toxicity in the pregnant rabbits exposed to
either 25 or 100 ppm EGEEA. The occurrence oftotal
litter resorption in three dams in the 400 ppm EGEEA
group cannot be conclusively associated with exposure
to EGEEA because the post-implantation loss in those
females with live fetuses in utero was no greater than
the controls, indicating that 400 ppm did not decrease
the number offetuses in surviving litters. However, the
reduction in mean litter weight as a result of reduced
fetal weight is evidence of fetotoxicity at 400 ppm.
There was also a reduction in mean fetal weights, but
not litter weight, in the group exposed to 100 ppm
EGEEA. While the reduction in mean fetal weight may
be attributable in part to the higherproportion oflitters
containing a large number of fetuses with subsequent
intralitter competition, it may be evidence of a slight
fetotoxic effect at 100 ppm EGEEA. There was no
evidence from the litter data of a fetotoxic effect at 25
ppm EGEEA.
Examination ofthe fetuses from the rabbits exposed
to 400 ppm confirmed fetotoxicity as indicated by
reduced fetal weight. There was reduced skeletal
ossification in both the vertebrae and the sternebrae,
increases in the numbers of thoracic ribs and an
increased incidence of slight renal pelvic dilatation.
Increased incidences of opaque gall bladders and small
spleens are difficult to interpret, and the biological
significance of these changes are unknown.
There was also some evidence offetotoxicity from the
skeletal examination of the fetuses from the rabbits
exposed to 100 ppm EGEEA. There was an increased
incidence of extra thoracic ribs and some retarded
ossification in the vertebral column and sternebrae
which only occurred in statistically significant numbers
where there was a greater instance at 400 ppm EGEEA
and therefore forming part of a dose-response rela-
tionship. None of these effects were seen in the
fetuses exposed to 25 ppm and this concentration is
therefore not fetotoxic.
At 400 ppm EGEEA there were five fetuses with
major skeletal malformations involving the vertebral
column; one fetus had asimilarmajorskeletalmalforma-
tion and agenesis ofone kidney; one fetus had moderate
dilatation of the brain ventricles, and one had mal-
rotation of the forelimbs. The incidence of six major
skeletal malformations compared with one in the con-
trols provides evidence of possible teratogenicity at
400 ppm EGEEA. The incidences of major external
and visceral abnormalities do not provide evidence
for teratogenicity at 400 ppm EGEEA. There was
no evidence of teratogenicity at either 100 ppm or
25 ppm EGEEA.
Although there were no cardiac abnormalities in this
study, the results are broadly similar to those reported
previously (4). Rats were exposed to 600, 390 or 130
ppm ofEGEEA. Then there was complete resorption of
all implants at 600 ppm EGEEA; at 390 ppm there was
fetotoxicity in the form of delayed ossification and
cardiac abnormality as evidence of teratogenicity.
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However, at 130 ppm EGEEA there was only one major
abnormality, a cardiac abnormality, and evidence of
fetotoxicity, i.e., an increased incidence of skeletal
defects, mainly delayed ossification.
The two studies together therefore indicate that 390
to 400 ppm EGEEA is teratogenic, 100 to 130 ppm
EGEEA is fetotoxic and that 25 ppm EGEEA is a
no-effect level.
These studies were sponsored by the Chemical Manufacturers
Association, Washington, DC.
The studies reported here were the result ofcollaboration between
the following: M. E. Killick, D. J. Tinston, G. A. Wickramaratne, M.
H. Litchfield with the aid ofM. Kilmartin, D. Kinsey, L. K. Head, S.
M. Millward, D. R. Woodcock, I. S. Chart, M. Godley and M. Thomas.
Thanks are due to L. Pritchard for typing the manuscript.
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